update

2025 ANNUAL NEALS MEETING

Thank You for Joining Us!

Thank you to everyone who joined us in Clearwater, FL and online for the 2025 NEALS Annual Meeting, held October 7–10. This year’s gathering brought together researchers, clinicians, industry partners, government representatives, foundations, and the ALS community to share the latest advances in ALS research, clinical trials, and collaboration.

Stay tuned announcements about the 2026 Annual Meeting — coming soon!

Our Mission

Our mission is to accelerate the development of new treatments through innovative research and working collaboratively with people living with ALS and all stakeholders in the ALS research community.

Search Trials

With support from The ALS Association, NEALS provides up-to-date information for finding both federally and privately funded clinical studies focusing on ALS and MND.

Contact an ALS Specialist

NEALS wants to make it easy for you to connect with a specialist. Use our search feature to find contact information for specialists in over 140 locations across the country and abroad.

Neals logo

Current Trials

Trials News & Events

The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Rapa Therapeutics have announced the first participant enrolled in the Expanded Access to RAPA-501 Protocol (EAP)

The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Rapa Therapeutics have announced the first participant enrolled in the Expanded Access to RAPA-501 Protocol (EAP). This EAP is sponsored by the National Institutes of Health (NIH) - Neurological Disorders and Stroke (NINDS), as part of the U.S. government’s landmark Accelerating Access to Critical Therapies for ALS Act (ACT for ALS).